Naproxen Naproxen 500 MG Oral Tablet
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of Naproxen Tablets and other treatment options before deciding to use Naproxen Tablets. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation ). Naproxen Tablets are indicated: • For the relief of the signs and symptoms of rheumatoid arthritis • For the relief of the signs and symptoms of osteoarthritis • For the relief of the signs and symptoms of ankylosing spondylitis • For the relief of the signs and symptoms of juvenile arthritis Naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. Naproxen Tablets are also indicated: • For relief of the signs and symptoms of tendonitis • For relief of the signs and symptoms of bursitis • For relief of the signs and symptoms of acute gout • For the management of pain • For the management of primary dysmenorrhea
Teva Pharmaceuticals USA Inc
OVAL RED Teva 149
Teva 149 OVAL RED
Related Pills
Naproxen Naproxen 500 MG Oral Tablet
Teva Pharmaceuticals USA Inc
Naproxen 250 MG Oral Tablet
Teva Pharmaceuticals USA Inc
Naproxen 500 MG Oral Tablet
REMEDYREPACK INC.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Naproxen Tablets USP are supplied as follows: 250 mg: Light brick red, mottled, round, biconvex, unscored tablets debossed with "93" on one side and "147" on the other. They are available in bottles of 100 (NDC 0093-0147-01) and 500 (NDC 0093-0147-05) tablets. 375 mg: peach, mottled, capsule-shaped, unscored tablets debossed with "93" on one side and "148" on the other. They are available in bottles of 100 (NDC 0093-0148-01) and 500 (NDC 0093-0148-05) tablets. 500 mg: Light brick red, mottled, capsule-shaped, unscored tablets debossed with "TEVA" on one side and "149" on the other. They are available in bottles of 100 (NDC 0093-0149-01), 500 (NDC 0093-0149-05) and 1000 (NDC 0093-0149-10) tablets. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Canada By: TEVA CANADA LIMITED Toronto, Canada M1B 2K9 Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. W 5/2016
More pills like OVAL Teva 149